Search Results 31-40 of 490 for ⚙[텔레 : USIMHONDA2] 선불유심내구제 선불유심내구제지식인 선불유심내구제자영업 선불유심내구제플랫폼 선불유심내구제총판⚙

  1. Faculty - Mayo Clinic Research

    The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...

  2. Faculty - Mayo Clinic Research

    The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...

  3. Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Clinical Trials - A Study to Evaluate MR of CSF Dynamics

    The purpose of this study is to evaluate changes in CSF dynamics (e.g., velocity, flow rate) between patients with normal pressure hydrocephalus and healthy ...

  5. CYP2C19 Genotype Predictor of Gastric Acid Suppression - Mayo Clinic

    About this study. If CYP2C19 genotype can predict the efficacy of healing erosive esophagitis and gastric acid secretion in patients taking once a day ...

  6. Publications

    Publications. Shanafelt TD, West CP, Sinsky C, Trockel M, Tutty M, Wang H, Carlasare LE, Dyrbye LN. Changes in Burnout and Satisfaction With Work-Life ...

  7. Contact - Mayo Clinic Research

    Researchers can contact the Center for Cell Signaling in Gastroenterology at Mayo Clinic about digestive diseases research, core services or collaborations.

  8. In Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the effectiveness and safety of Lubiprostone in pediatric patients, aged ≥ 6 years to < 18 years, diagnosed with ...

  9. Faculty - Mayo Clinic Research

    The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...

  10. Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, ...